Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatologists, Patient Advocacy Efforts Make a Difference

E. William St.Clair, MD  |  Issue: September 2015  |  September 15, 2015

The SGR repeal bill—the Medicare Access and CHIP Reauthorization Act (MACRA)—sets up an entirely new payment environment that will be further developed and phased in over the next several years. MACRA will change medical practice more than the ACA. Implementation of MACRA is a sea change for academic and hospital-based practices, and it has the potential to be an existential threat to many in private practice. These are just a few examples of what’s at stake. So it’s clear to me we’re in a high-stakes, high-pressure game. We need all fingers pointing in the same direction. Here’s what we can do.

Our Team Playbook

There are a number of tactics and strategies we can employ to succeed together. We have to be effective on both sides of the court.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

1) Reach out—Get known by your representatives

Each of us should know our lawmakers in Congress and state legislatures. Lawmakers listen to whom they know. How does each of us on the rheumatology team develop a meaningful relationship with lawmakers and get our message across?

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

We show up—our No. 1 tactic. When the game is on the line, we show up in Washington, D.C., as part of the ACR’s main fly-in, Advocates for Arthritis, and meet with lawmakers and their staff. I can tell you that the staff and lawmakers recognize us as we walk into their office wearing our Simple Tasks bent fork pins. We can also show up at our state capitols in the same way, where a lot of critical policy making takes place.

We show up at the local offices of members of Congress. These district offices are staffed with people whose jobs are to communicate with their constituents. There is nothing standing in the way of stopping by the local office and developing relationships with your representative or their staff. Another way to engage lawmakers is by inviting them to visit your practice. Most members of Congress are not aware that rheumatologists receive years of additional training to provide expert care to patients with arthritis and rheumatic conditions. What better way to show them the specialized care you provide than by inviting them to your office?

You can find contact information for your representatives at the ACR’s Legislative Action Center. You can also prepare by reviewing and sharing the ACR’s Issue Briefs, available on the ACR website in the advocacy section. Check out tips and resources on the ACR’s website. Feel free to contact ACR Government Affairs staff at 404-633-3777 or [email protected] for help.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:President's PerspectiveProfessional Topics Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)PatientsProfessional Mattersrheumatologistsrheumatology

Related Articles

    How to Survive MACRA

    April 19, 2017

    The year 2015 brought the end of the much-maligned Sustainable Growth Rate (SGR), sometimes known as the “doc fix.” The SGR established limits on Medicare reimbursement for physicians, and each year, physicians and those lobbying on their behalf were forced to stave off drastic cuts to their payments. “The SGR was Congress’s attempt to control…

    Prepare Now to Survive MACRA

    July 5, 2016

    The year 2015 brought an end to the much-maligned Sustainable Growth Rate (SGR), sometimes known as the “doc fix.” The SGR established limits on Medicare reimbursement for physicians, and each year, physicians and those lobbying on their behalf were forced to stave off drastic cuts to their payments. “The SGR was Congress’s attempt to control…

    Shifting Health Policy Landscape Brings Opportunities, Responsibility to Advocate for Rheumatology

    October 10, 2016

    Heraclitus of Ephesus (c. 500 BC) is credited with the saying, “The only constant is change.” Now, centuries later, change is meteoric, and especially in healthcare and health policy, the pace of change is relentless. Rheumatology and other specialties continue to face challenges that threaten the ability to deliver compassionate, competent care to patients. The…

    Brave New MACRA World

    October 18, 2016

    Sweeping changes in how physicians are paid for patient care are on the way. The Medicare Access and Children’s Health Insurance Program (CHIP) Reauthorization Act of 2015, or MACRA, tossed out the Sustainable Growth Rate formula and ties reimbursement to quality measures. A Helpful Presentation Because 2017 is the first performance year under the new…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences